OFF-LABEL DRUG-USE FOR CANCER-THERAPY AND NATIONAL-HEALTH CARE PRIORITIES

被引：9

作者：

MOERTEL, CG ^{[1
]}

机构：

[1] MAYO CLIN & MAYO FDN,DEPT ONCOL,ROCHESTER,MN 55905

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1991年 / 266卷 / 21期

关键词：

D O I：

10.1001/jama.266.21.3031

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3031 / 3032

页数：2

共 7 条

[1] DRUG PROMOTION AND SCIENTIFIC EXCHANGE - THE ROLE OF THE CLINICAL INVESTIGATOR [J].

KESSLER, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :201-203

[2]

LAETZ T, 1991, JAMA-J AM MED ASSOC, V266, P3023

[3]

MCCABE MS, 1991, P AN M AM SOC CLIN, V10, P213

[4] ANTITUMOR STRATEGIES BASED ON ENHANCING AND BLOCKING - EFFECTS OF INTERLEUKIN-2 [J].

MERZ, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (10) :1241-&

[5] AMA, PHARMACEUTICAL ASSOCIATION FORM SOLID FRONT ON GIFT-GIVING GUIDELINES [J].

RANDALL, T .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (18) :2304-2305

[6] OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER [J].

ROSENBERG, SA ;

LOTZE, MT ;

MUUL, LM ;

LEITMAN, S ;

CHANG, AE ;

ETTINGHAUSEN, SE ;

MATORY, YL ;

SKIBBER, JM ;

SHILONI, E ;

VETTO, JT ;

SEIPP, CA ;

SIMPSON, C ;

REICHERT, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (23) :1485-1492

[7]

1991, GAOPEMD9112BR US GEN

← 1 →